You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
碩世生物(688399.SH)擬2900萬元入夥葦渡阿爾法創業投資合夥企業 持股20.68%
格隆匯 05-18 20:46

格隆匯5月18日丨碩世生物(688399.SH)公佈,近日,公司擬與南京葦渡雲石管理諮詢合夥企業(有限合夥)等簽署《南京葦渡阿爾法創業投資合夥企業(有限合夥)合夥協議》。合夥協議簽署時合夥企業的認繳出資總額為人民幣1.402億元。合夥企業的總認繳出資額為不超過人民幣5億元。公司擬作為基金的有限合夥人以自有資金投資標的進行增資,公司本次投資總額為人民幣2900萬元,佔本次增資完成後合夥企業份額的20.6847%。

合夥企業為醫療產業投資基金,在全體合夥人最終實繳出資總額除去必要的合夥費用之外全部投資於新醫療健康產業(如數字醫療、智能醫療等)及相關周邊產業的新商業模式、新產品、新技術。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account